Scopus Asset Management’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-35,000
Closed -$1.58M 343
2021
Q2
$1.58M Sell
35,000
-25,000
-42% -$1.17M 0.02% 333
2021
Q1
$2.65M Buy
60,000
+10,000
+20% +$378K 0.03% 287
2020
Q4
$1.74M Buy
+50,000
New +$1.41M 0.03% 295

Other funds holding ADNT

Scopus Asset Management's ADNT Position: Q3 2022 in Review

Scopus Asset Management sold out of Adient (ADNT) in Q3 2022, closing a stake of 60,000 shares — an estimated $1.78M sold.

Scopus Asset Management first reported a position in ADNT in Q4 2020 and held it in 5 quarters. The position peaked at $9.26M in Q4 2020. 248 funds tracked by Wall St. Rank hold ADNT as of Q3 2022.

  • Scopus Asset Management reported no remaining Adient position as of Q3 2022 after selling out during the quarter.
  • Scopus Asset Management sold 60,000 Adient shares in Q3 2022, an estimated $1.78M.
  • Scopus Asset Management first reported a position in Adient in Q4 2020 and held it in 5 quarters.
  • Scopus Asset Management's Adient position peaked at $9.26M in Q4 2020.
  • 248 funds tracked by Wall St. Rank held Adient as of Q3 2022.

Based on Scopus Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.